Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Prehospital exenatide in hyperglycemic stroke - a randomized trial.

Larsson M, Castren M, Lindström V, von Euler M, Patrone C, Wahlgren N, Nathanson D.

Acta Neurol Scand. 2019 Sep 13. doi: 10.1111/ane.13166. [Epub ahead of print]

PMID:
31518433
2.

GLP-1 secretion in acute ischemic stroke: association with functional outcome and comparison with healthy individuals.

Larsson M, Patrone C, von Euler M, Holst JJ, Nathanson D.

Cardiovasc Diabetol. 2019 Jul 15;18(1):91. doi: 10.1186/s12933-019-0896-z.

3.

Obesity-induced type 2 diabetes impairs neurological recovery after stroke in correlation with decreased neurogenesis and persistent atrophy of parvalbumin-positive interneurons.

Pintana H, Lietzau G, Augestad IL, Chiazza F, Nyström T, Patrone C, Darsalia V.

Clin Sci (Lond). 2019 Jul 1;133(13):1367-1386. doi: 10.1042/CS20190180. Print 2019 Jul 15.

PMID:
31235555
4.

Dipeptidyl Peptidase-4 Inhibitors for the Potential Treatment of Brain Disorders; A Mini-Review With Special Focus on Linagliptin and Stroke.

Darsalia V, Johansen OE, Lietzau G, Nyström T, Klein T, Patrone C.

Front Neurol. 2019 May 8;10:493. doi: 10.3389/fneur.2019.00493. eCollection 2019. Review.

5.

Harnessing the synergistic potential of biologically targeted therapies in cutaneous T-cell lymphoma.

Patrone CC, Geskin LJ.

Oncotarget. 2019 Mar 8;10(20):1860-1861. doi: 10.18632/oncotarget.26751. eCollection 2019 Mar 8. No abstract available.

6.

An Integrated Data Resource for Genomic Analysis of Cutaneous T-Cell Lymphoma.

Chang LW, Patrone CC, Yang W, Rabionet R, Gallardo F, Espinet B, Sharma MK, Girardi M, Tensen CP, Vermeer M, Geskin LJ.

J Invest Dermatol. 2018 Dec;138(12):2681-2683. doi: 10.1016/j.jid.2018.06.176. Epub 2018 Jul 5. No abstract available.

PMID:
29981755
7.

The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway.

Chiazza F, Tammen H, Pintana H, Lietzau G, Collino M, Nyström T, Klein T, Darsalia V, Patrone C.

Cardiovasc Diabetol. 2018 May 19;17(1):60. doi: 10.1186/s12933-018-0702-3.

8.

Three antigen-loading methods in dendritic cell vaccines for metastatic melanoma.

Geskin LJ, Damiano JJ, Patrone CC, Butterfield LH, Kirkwood JM, Falo LD.

Melanoma Res. 2018 Jun;28(3):211-221. doi: 10.1097/CMR.0000000000000441.

PMID:
29543704
9.

Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin.

Lietzau G, Davidsson W, Östenson CG, Chiazza F, Nathanson D, Pintana H, Skogsberg J, Klein T, Nyström T, Darsalia V, Patrone C.

Acta Neuropathol Commun. 2018 Feb 23;6(1):14. doi: 10.1186/s40478-018-0517-1.

10.

The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors.

Darsalia V, Larsson M, Klein T, Patrone C.

Cardiovasc Diabetol. 2018 Feb 21;17(1):32. doi: 10.1186/s12933-018-0674-3. No abstract available.

11.

Highly Sensitive Virome Capture Sequencing Technique VirCapSeq-VERT Identifies Partial Noncoding Sequences but no Active Viral Infection in Cutaneous T-Cell Lymphoma.

Anderson ME, Nagy-Szakal D, Jain K, Patrone CC, Frattini MG, Lipkin WI, Geskin LJ.

J Invest Dermatol. 2018 Jul;138(7):1671-1673. doi: 10.1016/j.jid.2018.01.024. Epub 2018 Feb 7. No abstract available.

12.

Clinical Insights and Emerging Strategies in Managing Cutaneous T-Cell Lymphoma.

Patrone CC, Geskin LJ.

J Drugs Dermatol. 2017 May 1;16(5):405-412. Review.

PMID:
29028854
13.

Glucagon-like receptor 1 agonists and DPP-4 inhibitors: Anti-diabetic drugs with anti-stroke potential.

Darsalia V, Klein T, Nyström T, Patrone C.

Neuropharmacology. 2018 Jul 1;136(Pt B):280-286. doi: 10.1016/j.neuropharm.2017.08.022. Epub 2017 Aug 18. Review.

PMID:
28823610
14.

Type 2 diabetes alters hippocampal gamma oscillations: A potential mechanism behind impaired cognition.

Lietzau G, Darsalia V, Pintana H, Östenson CG, Nyström T, Fisahn A, Patrone C.

Psychoneuroendocrinology. 2017 Aug;82:46-50. doi: 10.1016/j.psyneuen.2017.04.012. Epub 2017 Apr 27.

PMID:
28501550
15.

PACAP Protects Adult Neural Stem Cells from the Neurotoxic Effect of Ketamine Associated with Decreased Apoptosis, ER Stress and mTOR Pathway Activation.

Mansouri S, Agartz I, Ögren SO, Patrone C, Lundberg M.

PLoS One. 2017 Jan 26;12(1):e0170496. doi: 10.1371/journal.pone.0170496. eCollection 2017.

16.

Diabetes negatively affects cortical and striatal GABAergic neurons: an effect that is partially counteracted by exendin-4.

Larsson M, Lietzau G, Nathanson D, Östenson CG, Mallard C, Johansson ME, Nyström T, Patrone C, Darsalia V.

Biosci Rep. 2016 Dec 5;36(6). pii: e00421. doi: 10.1042/BSR20160437. Print 2016 Dec.

17.

Pituitary Adenlylate Cyclase Activating Peptide Protects Adult Neural Stem Cells from a Hypoglycaemic milieu.

Mansouri S, Lietzau G, Lundberg M, Nathanson D, Nyström T, Patrone C.

PLoS One. 2016 Jun 15;11(6):e0156867. doi: 10.1371/journal.pone.0156867. eCollection 2016.

18.

Gliptin-mediated neuroprotection against stroke requires chronic pretreatment and is independent of glucagon-like peptide-1 receptor.

Darsalia V, Larsson M, Lietzau G, Nathanson D, Nyström T, Klein T, Patrone C.

Diabetes Obes Metab. 2016 May;18(5):537-41. doi: 10.1111/dom.12641. Epub 2016 Mar 17. Erratum in: Diabetes Obes Metab. 2018 Apr;20(4):1086.

PMID:
26847506
19.

Type 2 diabetes-induced neuronal pathology in the piriform cortex of the rat is reversed by the GLP-1 receptor agonist exendin-4.

Lietzau G, Nyström T, Östenson CG, Darsalia V, Patrone C.

Oncotarget. 2016 Feb 2;7(5):5865-76. doi: 10.18632/oncotarget.6823.

20.

A modified approach to thyroid exams.

Chung MK, Patrone CC, LaRiccia PJ.

J Fam Pract. 2015 Feb;64(2):83. No abstract available.

PMID:
25671527
21.

Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke.

Darsalia V, Larsson M, Nathanson D, Klein T, Nyström T, Patrone C.

J Cereb Blood Flow Metab. 2015 May;35(5):718-23. doi: 10.1038/jcbfm.2015.17. Epub 2015 Feb 11. Review.

22.

Sex, diastolic blood pressure, and outcome after thrombolysis for ischemic stroke.

Nathanson D, Patrone C, Nyström T, von Euler M.

Stroke Res Treat. 2014;2014:747458. doi: 10.1155/2014/747458. Epub 2014 Sep 15.

23.

Exendin-4 reduces ischemic brain injury in normal and aged type 2 diabetic mice and promotes microglial M2 polarization.

Darsalia V, Hua S, Larsson M, Mallard C, Nathanson D, Nyström T, Sjöholm Å, Johansson ME, Patrone C.

PLoS One. 2014 Aug 7;9(8):e103114. doi: 10.1371/journal.pone.0103114. eCollection 2014.

24.

Linagliptin enhances neural stem cell proliferation after stroke in type 2 diabetic mice.

Darsalia V, Olverling A, Larsson M, Mansouri S, Nathanson D, Nyström T, Klein T, Sjöholm Å, Patrone C.

Regul Pept. 2014 May;190-191:25-31. doi: 10.1016/j.regpep.2014.05.001. Epub 2014 May 10.

PMID:
24821550
25.

GLP-1R activation for the treatment of stroke: updating and future perspectives.

Darsalia V, Nathanson D, Nyström T, Klein T, Sjöholm Å, Patrone C.

Rev Endocr Metab Disord. 2014 Sep;15(3):233-42. doi: 10.1007/s11154-014-9285-9.

PMID:
24777909
26.

Evidence for cortical neuronal loss in male type 2 diabetic Goto-Kakizaki rats.

Hussain S, Mansouri S, Sjöholm Å, Patrone C, Darsalia V.

J Alzheimers Dis. 2014;41(2):551-60. doi: 10.3233/JAD-131958.

PMID:
24643136
27.

Diabetes drugs and neurological disorders: new views and therapeutic possibilities.

Patrone C, Eriksson O, Lindholm D.

Lancet Diabetes Endocrinol. 2014 Mar;2(3):256-62. doi: 10.1016/S2213-8587(13)70125-6. Epub 2013 Nov 22.

PMID:
24622756
28.

GalR3 activation promotes adult neural stem cell survival in response to a diabetic milieu.

Mansouri S, Barde S, Ortsäter H, Eweida M, Darsalia V, Langel U, Sjöholm A, Hökfelt T, Patrone C.

J Neurochem. 2013 Oct;127(2):209-20. doi: 10.1111/jnc.12396. Epub 2013 Sep 3.

29.

GLP-1 secretion by microglial cells and decreased CNS expression in obesity.

Kappe C, Tracy LM, Patrone C, Iverfeldt K, Sjöholm Å.

J Neuroinflammation. 2012 Dec 23;9:276. doi: 10.1186/1742-2094-9-276.

30.

The DPP-4 inhibitor linagliptin counteracts stroke in the normal and diabetic mouse brain: a comparison with glimepiride.

Darsalia V, Ortsäter H, Olverling A, Darlöf E, Wolbert P, Nyström T, Klein T, Sjöholm Å, Patrone C.

Diabetes. 2013 Apr;62(4):1289-96. doi: 10.2337/db12-0988. Epub 2012 Dec 3.

31.

The specific VPAC2 agonist Bay 55-9837 increases neuronal damage and hemorrhagic transformation after stroke in type 2 diabetic rats.

Darsalia V, Mansouri S, Wolbert P, Barde S, Sjöholm A, Patrone C.

Neuropeptides. 2013 Apr;47(2):133-7. doi: 10.1016/j.npep.2012.08.008. Epub 2012 Sep 13.

PMID:
22981158
32.

Metformin protects against lipoapoptosis and enhances GLP-1 secretion from GLP-1-producing cells.

Kappe C, Patrone C, Holst JJ, Zhang Q, Sjöholm A.

J Gastroenterol. 2013 Mar;48(3):322-32. doi: 10.1007/s00535-012-0637-5. Epub 2012 Aug 2.

PMID:
22850868
33.

Pituitary adenylate cyclase-activating polypeptide counteracts the impaired adult neural stem cell viability induced by palmitate.

Mansouri S, Ortsäter H, Pintor Gallego O, Darsalia V, Sjöholm A, Patrone C.

J Neurosci Res. 2012 Apr;90(4):759-68. doi: 10.1002/jnr.22803. Epub 2011 Dec 20.

PMID:
22183970
34.

Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats.

Darsalia V, Mansouri S, Ortsäter H, Olverling A, Nozadze N, Kappe C, Iverfeldt K, Tracy LM, Grankvist N, Sjöholm Å, Patrone C.

Clin Sci (Lond). 2012 May 1;122(10):473-83. doi: 10.1042/CS20110374.

35.

Restorative effects of platelet derived growth factor-BB in rodent models of Parkinson's disease.

Zachrisson O, Zhao M, Andersson A, Dannaeus K, Häggblad J, Isacson R, Nielsen E, Patrone C, Rönnholm H, Wikstrom L, Delfani K, McCormack AL, Palmer T, Di Monte DA, Hill MP, Janson Lang AM, Haegerstrand A.

J Parkinsons Dis. 2011;1(1):49-63. doi: 10.3233/JPD-2011-0003.

PMID:
23939256
36.

The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test.

Isacson R, Nielsen E, Dannaeus K, Bertilsson G, Patrone C, Zachrisson O, Wikström L.

Eur J Pharmacol. 2011 Jan 10;650(1):249-55. doi: 10.1016/j.ejphar.2010.10.008. Epub 2010 Oct 14.

PMID:
20951130
37.

Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease.

Bertilsson G, Patrone C, Zachrisson O, Andersson A, Dannaeus K, Heidrich J, Kortesmaa J, Mercer A, Nielsen E, Rönnholm H, Wikström L.

J Neurosci Res. 2008 Feb 1;86(2):326-38.

PMID:
17803225
38.

PACAP promotes neural stem cell proliferation in adult mouse brain.

Mercer A, Rönnholm H, Holmberg J, Lundh H, Heidrich J, Zachrisson O, Ossoinak A, Frisén J, Patrone C.

J Neurosci Res. 2004 Apr 15;76(2):205-15.

PMID:
15048918
39.

Regulation of postnatal lung development and homeostasis by estrogen receptor beta.

Patrone C, Cassel TN, Pettersson K, Piao YS, Cheng G, Ciana P, Maggi A, Warner M, Gustafsson JA, Nord M.

Mol Cell Biol. 2003 Dec;23(23):8542-52.

40.

Oestrogen prevention of neural cell death correlates with decreased expression of mRNA for the pro-apoptotic protein nip-2.

Meda C, Vegeto E, Pollio G, Ciana P, Patrone C, Pellicciari C, Maggi A.

J Neuroendocrinol. 2000 Nov;12(11):1051-9.

PMID:
11069120
41.

Estradiol induces differential neuronal phenotypes by activating estrogen receptor alpha or beta.

Patrone C, Pollio G, Vegeto E, Enmark E, de Curtis I, Gustafsson JA, Maggi A.

Endocrinology. 2000 May;141(5):1839-45.

PMID:
10803594
42.

Estrogen receptor-dependent regulation of sensory neuron survival in developing dorsal root ganglion.

Patrone C, Andersson S, Korhonen L, Lindholm D.

Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10905-10.

44.

Divergent pathways regulate ligand-independent activation of ER alpha in SK-N-BE neuroblastoma and COS-1 renal carcinoma cells.

Patrone C, Gianazza E, Santagati S, Agrati P, Maggi A.

Mol Endocrinol. 1998 Jun;12(6):835-41.

PMID:
9626659
45.

Oligonucleotide squelching reveals the mechanism of estrogen receptor autologous down-regulation.

Santagati S, Gianazza E, Agrati P, Vegeto E, Patrone C, Pollio G, Maggi A.

Mol Endocrinol. 1997 Jun;11(7):938-49.

46.

Dopaminergic phenotype induced by oestrogens in a human neuroblastoma cell line.

Agrati P, Ma ZQ, Patrone C, Picotti GB, Pellicciari C, Bondiolotti G, Bottone MG, Maggi A.

Eur J Neurosci. 1997 May;9(5):1008-16. Erratum in: Eur J Neurosci 1997 Jul;9(7):1552.

PMID:
9182953
47.

SK-ER3 neuroblastoma cells as a model for the study of estrogen influence on neural cells.

Agrati P, Garnier M, Patrone C, Pollio G, Santagati S, Vegeto E, Maggi A.

Brain Res Bull. 1997;44(4):519-23.

48.

Cross-coupling between insulin and estrogen receptor in human neuroblastoma cells.

Patrone C, Ma ZQ, Pollio G, Agrati P, Parker MG, Maggi A.

Mol Endocrinol. 1996 May;10(5):499-507.

PMID:
8732681
49.

Specificity of action of a herpes virus VP16/tetracycline-dependent trans-activator in mammalian cell cultures.

Magalini A, Ferrari F, Savoldi G, Ingrassia R, Albertini A, Pollio G, Patrone C, Maggi A, Di Lorenzo D.

DNA Cell Biol. 1995 Aug;14(8):665-71.

PMID:
7646813
50.

Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3.

Ma ZQ, Santagati S, Patrone C, Pollio G, Vegeto E, Maggi A.

Mol Endocrinol. 1994 Jul;8(7):910-8.

PMID:
7984152

Supplemental Content

Loading ...
Support Center